AOL Money & Finance

Earnings preview: Homebuilders Centex, Pulte Homes, and DR Horton

More

Given last week's news that new home sales have plunged and that new home prices continue to fall, what is Wall Street expecting from homebuilders Centex Corp. (NYSE: CTX), Pulte Homes Inc. (NYSE: PHM), and DR Horton Inc. (NYSE: DHI) when they report quarterly results this week?

Analysts surveyed by Thomson Reuters anticipate that Dallas-based Centex will report that it narrowed its net loss in its fiscal third quarter to $3.27 per share. In the same period of last year, the loss was $7.94 per share. Revenue in the third quarter is expected to total $895.3 million, down 53.0% from last year. For the full year, the loss is expected to reach $7.36 per share on revenue of $4.0 billion, which compares to a $21.69 per share loss on $8.3 billion in sales in 2008. Centex has posted bigger-than-expected losses in the past five quarters. So the consensus recommendation of analysts remains to hold CTX, though the long-range EPS growth forecast is 9.0%. The share price has fallen 20.0% just since the beginning of the year, and it is 70.7% lower than it was a year ago. Centex suspended its quarterly dividends back in October.

Pulte Homes, one of the largest homebuilders in the U.S., is expected to report that it narrowed its net loss as well in its fourth quarter. The projected $0.71 per share loss compares to a $3.54 per-share loss in the same period of last year. Revenue in the recent quarter is expected to come to $1.4 billion, down 50.5% from last year. For the full year, the loss is expected to be $5.02 per share on revenue of $6.1 billion, which compares to a $9.02 per share loss and $9.3 billion in sales in 2007. Pulte has posted bigger-than-expected losses in four of the past five quarters. The long-range EPS growth forecast is 10.0%, and the consensus recommendation of analysts remains to hold PHM. The share price is closer to the 52-week low than the 52-week high and is 35.1% lower than it was a year ago. Pulte has also suspended its quarterly dividends.

Fort Worth, Tex.-based DR Horton, on the other hand, is expected to have widened its net loss by 21.2% from last year to $0.52 per share. Revenue for the fiscal first quarter is forecast to be $918.2 million, which is 47.3% lower than last year. So far, the full-year loss is expected to come to $1.27 per share on revenue of $3.9 billion, which compares to a $8.34 per share loss and $6.7 billion in revenue in 2008. DR Horton has posted bigger-than-expected losses in the past four quarters. The long-range EPS growth forecast is only 7.6%, and, no surprise, the consensus recommendation remains to hold DHI. The share price has fallen 19.2% in the past three months, and shares are 65.6% lower than it was a year ago.

Visit AOL Money & Finance for more earnings coverage.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+17.4610,023.42
NASDAQ+7.122,112.44
S&P 500+2.671,069.30

Last updated: November 08, 2009: 09:08 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines